Cold Agglutinin Disease (CAD) can cause blood samples to produce inaccurate or failed laboratory results if they are allowed to cool after collection.
In some CAD patients, blood specimens must be kept warm from the moment of collection through final laboratory analysis and tested STAT (meaning immediately).
This page provides a quick reference list of affected tests, followed by plain-language explanations for patients and medically accurate guidance for phlebotomists, laboratories, and clinicians.
Quick Reference: Tests Affected by CAD Cold Sensitivity
The following tests may fail, produce inaccurate results, or require special handling in patients with Cold Agglutinin Disease if specimens are not kept warm and processed promptly:
- CBC / RBC (Complete Blood Count and red blood cell indices)
- Hemoglobin
- Hematocrit
- MCV (mean corpuscular volume)
- MCH (mean corpuscular hemoglobin)
- MCHC (mean corpuscular hemoglobin concentration)
- RDW (red cell distribution width)
- Reticulocyte Count
- Reticulocyte Hemoglobin Content (Ret-He or CHr)
- Peripheral Blood Smear / Red Blood Cell Morphology
- Cold Agglutinin Titer
- Thermal Amplitude Test
- Direct Antiglobulin Test (DAT / Direct Coombs)
- ABO and Rh Blood Typing (transfusion settings)
- Antibody Screen
- Antibody Identification
- Crossmatch / Compatibility Testing
- Flow Cytometry (blood or bone marrow–based studies)
- Bone marrow aspirate studies involving red cell analysis
Clinical (non-test) considerations related to CAD cold sensitivity include blood transfusions, IV fluids containing saline, plasma, or blood products, and blood-contaminated cellular specimens or aspirates.
Key principle:
In CAD patients with sufficient cold sensitivity, specimens may need to be kept near body temperature (approximately 37°C / 98.6°F) from collection through analysis and processed STAT to avoid red blood cell clumping and inaccurate results.
What is Cold Agglutinin Disease (CAD)
Cold Agglutinin Disease is an autoimmune condition in which the immune system produces antibodies, most commonly IgM, that bind to red blood cells at cooler temperatures.
Agglutination means red blood cells stick together or clump.
Hemolysis means red blood cells are damaged or destroyed.
In CAD, these reactions can occur inside a blood tube after the draw if the sample cools, even if the patient feels fine and has no obvious symptoms.
Why Temperature Matters for Testing
When a CAD blood sample cools:
- Red blood cells may clump together
- Automated analyzers may miscount cells
- Results may appear falsely low, falsely high, or internally inconsistent
- Labs may report sample failure, clotted specimen, or invalid indices
Once clumping occurs, reheating the specimen later may not correct the problem, especially in more cold-sensitive CAD patients.
End-to-End Handling Principle
For CAD patients whose tests show analyzer flags or inconsistent values, many laboratories require a continuous warm chain:
- Notify staff in advance that the patient has CAD
- Pre-warm collection tubes when required
- Keep specimens warm after collection
- Avoid cold surfaces and processing delays
- Hand-deliver specimens to the lab when possible
- Run affected tests STAT (immediately)
This requires coordination between the phlebotomist, transport staff, and laboratory personnel.
Tests Most Affected by CAD
CBC and related red blood cell measurements are the most commonly affected tests.
Cold clumping can cause falsely low red blood cell counts, incorrect hematocrit, and abnormal calculated indices such as MCV and MCHC.
Reticulocyte testing is also affected. Reticulocytes are immature red blood cells used to assess bone marrow response. Cold agglutination can produce falsely low or invalid reticulocyte counts and misleading interpretations of anemia severity.
Peripheral blood smears can show exaggerated clumping if the specimen cools, making interpretation difficult unless CAD is recognized.
CAD-Specific Immunohematology Tests
Cold Agglutinin Titers and Thermal Amplitude testing require careful temperature control. Cooling can distort results or produce false negatives.
The Direct Antiglobulin Test (DAT or Direct Coombs) is commonly positive for complement in CAD. Handling requirements are method-dependent and should follow CAD-aware laboratory protocol rather than blanket warming without guidance.
Transfusion and Blood Bank Testing
CAD can interfere with blood typing, antibody screens, antibody identification, and crossmatching. Blood banks often use pre-warm techniques at body temperature to avoid cold antibody interference.
Other Specimens and Clinical Considerations
Most solid tissue biopsies are not affected by CAD. However, blood-contaminated aspirates or cellular suspensions may require special handling depending on laboratory methods.
Highly cold-reactive CAD patients may require warming of blood transfusions and IV fluids to prevent in-body clumping. This is a clinical safety issue rather than a laboratory accuracy issue.
Documentation Matters
Written instructions from a hematologist on official letterhead, credentials, Dr Signature and dates, are strongly recommended for CAD patients who require special handling.
Documentation should state the need to keep specimens warm and to process certain tests STAT.
This is especially important for emergency departments, hospital admissions,
blood transfusion possibilities, and new facilities unfamiliar with CAD.
Plain-Language Takeaway
Cold Agglutinin Disease can cause blood samples to clump if they cool,
leading to failed or incorrect test results.
Keeping certain specimens warm from start to finish and testing them immediately prevents many errors.
CBC and reticulocyte testing are most affected, but other specialized tests can also be impacted.
